Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
5
×
life sciences
medicare
5
×
merck
5
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
5
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
pfizer
abbvie
amgen
biogen
bristol-myers squibb
cancer
deals
diagnostics
drug prices
gene therapy
What
bio
drug
roundup
patients
new
talk
today
acquisitions
advantages
albert
approval
away
bar
becker
biggest
billions
biogen’s
biopharmaceutical
bourla
bringing
brings
ceo
ceos
companies
company
convo
crispr
dc
dollars
earlier
eaton
executives
expect
failures
future
gamble
gathered
gene
groups
healthcare
Language
unknown
unset
Current search:
merck
×
medicare
×
" san francisco top stories "
×
" indiana top stories "
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away